Bortezomib will enhance the degree or outcome of flibanserin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. Greater flibanserin adverse effects may possibly happen if coadministered with several weak CYP3A4 inhibitors. Remedy triggers peripheral neuropathy (predominantly sensory); even so, situations of significant sensory and motor peripheral neuropathy ... https://reubeng444sdn6.blogpayz.com/profile